Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Anus Neoplasms × Sentinel Lymph Node Biopsy × Clear all

Status

Sponsor Class

Study Type

Observational 1 Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Intraductal, Noninfiltrating 3 Uterine Cervical Neoplasms 2 Breast Neoplasms 2 Vulvar Neoplasms 1 Sentinel Lymph Node 1 Neoplasm Micrometastasis 1 FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma 1 Endometrial Neoplasms 1 Eccrine Porocarcinoma 1 Breast Carcinoma In Situ 1 Anus Neoplasms 1

Interventions

Surveys and Questionnaires 4 Biopsy 2 trastuzumab deruxtecan 1 Tomography, X-Ray Computed 1 Sentinel Lymph Node Biopsy 1 Restraint, Physical 1 Radiotherapy 1 Radionuclide Imaging 1 Quality of Life 1 Psychiatric Rehabilitation 1 Positron-Emission Tomography 1 Observation 1 Mass Screening 1 Magnetic Resonance Spectroscopy 1 Immunohistochemistry 1 Human Papillomavirus DNA Tests 1 Follow-Up Studies 1 Drug Therapy 1 Chromatin Immunoprecipitation Sequencing 1 Blood Specimen Collection 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02162641 2015-06-03

R-SeNSAR

The Christie NHS Foundation Trust

Gastrointestinal

Anus Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡